【Vitafoods Asia Live】How to Get High But No Harm to the Heart? Hughes Biotech Sparks Intense Dialogue in Bangkok with RenoFlavone

BANGKOK, THAILAND — At the recently concluded Vitafoods Asia, the region’s premier nutraceutical event, one booth consistently drew crowds with a bold, thought-provoking headline: “How to get high but no harm with heart?”

Presented by Hughes Biotech, this timely theme directly addressed the most buzzing topic in the host nation—Thailand’s recent landmark decriminalization of cannabis. As cannabis-infused foods, beverages, and wellness products flood the Southeast Asian market, consumer enthusiasm is at an all-time high. However, beneath the green rush, medical experts and scientists are raising critical red flags regarding cardiovascular safety.

The Hidden Threat: THC’s Impact on the Heart

The “high” from cannabis comes from THC (Tetrahydrocannabinol) interacting with our central nervous system. However, this psychological bliss carries a physiological cost.

THC binds strongly to Cannabinoid Receptor 1 (CB1), which is heavily expressed throughout the cardiovascular system. A groundbreaking 2022 study published on Cell by Stanford Medicine revealed that hyperactivation of the CB1 receptor by THC triggers severe vascular inflammation, oxidative stress, and cell death. This directly worsens conditions like atherosclerosis, heart failure, and diabetic cardiomyopathy.

The Stanford Breakthrough: Genistein as the Molecular Shield

To mitigate these cardiovascular risks without erasing the psychoactive benefits of cannabis, Stanford researchers found an answer in Genistein, a natural isoflavone abundant in soybeans.

Genistein acts as a powerful strong inhibitor (antagonist) of the CB1 receptor. It effectively blocks CB1 hyperactivation, reducing vascular inflammation and oxidative stress without interfering with THC’s ability to deliver its desired effects in the brain.

Hughes Biotech’s RenoFlavone: Solving the Bioavailability Bottleneck

Despite its benefits, standard genistein faces a major hurdle: extremely poor oral bioavailability, making ordinary supplements largely ineffective.

Hughes Biotech bridges this gap with RenoFlavone, a premium functional ingredient featuring highly bioavailable genistein. Through proprietary biotechnology, RenoFlavone overcomes the absorption bottleneck, ensuring efficient levels of genistein enter the bloodstream to offer advanced nutritional defense for cardiovascular well-being.

A New Frontier for Cannabis and Cardiovascular Wellness

As the global cannabis and functional food markets expand rapidly, RenoFlavone offers brands a monumental marketing angle and a tangible formulation solution.

By pairing bold consumer lifestyle trends with rigorous scientific safety, RenoFlavone serves as the missing puzzle piece—allowing consumers to confidently explore wellness trends while proactively safeguarding their cardiovascular health.